Amanote Research

Amanote Research

    RegisterSign In

Gabepentinoids and Benzodiazepines in Medicare Part D

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2018070745
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineNephrology
Date

September 21, 2018

Authors
Eric D. Weinhandl
Publisher

American Society of Nephrology (ASN)


Related search

Medicare Part D Payments for Topical Steroids

JAMA Dermatology
DermatologyMedicine
2017English

Changes to Medicare Part D: Who Benefits?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2010English

Pre-Medicare Eligible Individuals' Decision-Making in Medicare Part D: An Interview Study

INNOVATIONS in pharmacy
2010English

Government Payments and Insurer Benefit Design in Medicare Part D

SSRN Electronic Journal
2014English

Radiation Oncology Drug Prescription Patterns in Medicare Part D

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Medicare Part D Payments for Neurologist-Prescribed Drugs

Neurology
Neurology
2016English

Medicare Part D and Quality of Prescription Medication Use in Older Adults

Drugs and Aging
GerontologyGeriatricsPharmacology
2011English

Pin73 - Economic Burden of Hiv/Aids Among Elderly Medicare Beneficiaries Post Medicare Part D

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Inattention and Switching Costs as Sources of Inertia in Medicare Part D

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy